Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150] (S0303720716304853)(10.1016/j.mce.2016.11.016)

A. W. Nelson, A. J. Groen, J. L. Miller, A. Y. Warren, K. A. Holmes, G. A. Tarulli, W. D. Tilley, B. S. Katzenellenbogen, J. R. Hawse, V. J. Gnanapragasam, J. S. Carroll

Research output: Contribution to journalComment/debate

2 Scopus citations

Abstract

The authors regret that some of the information in Table 2 is incorrect. The correct text should read: CWK-F12 Recombinant fusion protein. Amino acids 256–505 of human wt ERb Mouse Monoclonal C-terminus WB, IP, IHC. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Pages (from-to)175
Number of pages1
JournalMolecular and Cellular Endocrinology
Volume443
DOIs
StatePublished - Mar 5 2017

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Endocrinology

Fingerprint Dive into the research topics of 'Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150] (S0303720716304853)(10.1016/j.mce.2016.11.016)'. Together they form a unique fingerprint.

  • Cite this